Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

Go back to Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.29 --0 (-0%)
Previous Close $0.29    52 Week High $31.32 
Open $0.29    52 Week Low $13.95 
Day High $0.30    P/E N/A 
Day Low $0.28    EPS $-3.29 
Volume 1,568,936